Patent · US Active

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

US7547452B2 · kind B2 · utility

5Cited by

67References

5Claims

0Family size

Assignees

Alkermes, Inc. · US
Janssen Pharmaceutica NA · BE

Inventors

Thomas J. Atkins · Wilmington, US
Michael E. Rickey · Morrow, US
Jean Mesens · Wechelderzande, BE

Key dates

Filing date	Jul 13, 2007
Grant date	Jun 16, 2009
Priority date	—
Expiry date	Jul 13, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Sustained-release microparticle composition. The microparticle composition can be formulated to provide extended release over a period of from about 7 days to about 200 days. The microparticles may be formulated with a biodegradable and biocompatible polymer, and an active agent, such as risperidone, 9-hydroxy-risperidone, and pharmaceutically acceptable acid addition salts of the foregoing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.